Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2024-02-13 00:00:00 ET · period of report 2024-02-09 · accession 0001209191-24-003238 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-13 | 2024-02-09 | RXRX | Secora Michael | CFO | F - Tax | $10.09 | -2,512 | 1.16M | -0.2% | -$25.3K |
| DM | 2024-02-13 | 2024-02-09 | RXRX | Secora Michael | CFO | A - Grant | $0.00 | +182.8K | 989.7K | +23% | $0 |
| D | 2024-02-13 | 2024-02-09 | RXRX | Secora Michael | CFO | A - Grant | $0.00 | +348.4K | 348.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-02-09 | F | D | 2,512 | $10.09 | 1,161,351 | D | — | — | |
| 2 | Common | Class A Common Stock | 2024-02-09 | A | A | 174,190 | $0.00 | 1,163,863 | D | — | — | |
| 3 | Common | Class A Common Stock | 2024-02-09 | A | A | 8,659 | $0.00 | 989,673 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2024-02-09 | A | A | 348,380 | $0.00 | 348,380 | D | $10.09 · — to 2034-02-09 | 348,380 Class A Common Stock | (F8) The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. |